Galderma buys CollaGenex for $420m

Written by on February 26, 2008 in Galderma, Metrogel 1%, Oracea (40mg doxycycline) with 1 Comment

Collagenex is set to become a subsidiary of the much bigger Galderma, after CollaGenex agreed to a merger. So 2 of the biggest pharmaceutical companies involved with make rosacea treatments are to become the same company.

Galderma has long been associated with rosacea treatment, and is best known for the metronidazole based topicals metrogel, metrocream and metrolotion. CollaGenex has become known in recent years for their promotion of the oral rosacea treatment Oracea. Further, Collagenex is developing the Sansrosa technology as topical treatment for the redness and flushing of rosacea.

Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal.

It seems like an excellent fit to me with both offering complimentary products. Additionally it is also good news for the creation of new rosacea treatments as the combined resources of the 2 companies can be targeted toward new products.

Read some further news coverage:

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

1 Reader Comment

  1. ben says:

    Yes, I hope this is good news. Collagenex has a much better feel of the “pulse” of rosacea than Galderma does, so hopefully rosacea sufferers’ interests will not get drowned out in the noise.

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.